Cardio-Oncology Community

Loading the player...

Intersections between the Vascular System and Cancer

Kathleen Martin, PhD interviews Rosandra Kaplan, MD about her research on intersections between the vascular system and cancer, which she presented during Vascular Discovery 2019. See highlighted science from the conference.

Science News

CIRCULATION | Editor's Picks | May/June 2019
06/19/2019 | CIRCULATON Editor's Picks for May/June 2019
Cardio-Oncology Rehab to Manage CV Outcomes in Cancer Patients and Survivors
04/08/2019 | This statement introduces the concept of cardio-oncology rehabilitation, which is important for the more than 16.7 million cancer survivo...
Cardio-Oncology: Vascular and Metabolic Perspective
02/21/2019 | Cardio-oncology, which focuses on the intersection of heart conditions in patients who have been treated for cancer, has developed as a n...

Scientific Sessions 2019

Scientific Sessions: Nov. 16–18
 

Philadelphia, Pennsylvania
 

Related Councils

Council on Clinical Cardiology (CLCD)

Randal J. Thomas, MD MS FAHA FACC MAACVPR

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Randal J. Thomas, MD, MS, FAHA, FACC, MAACVPR
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Genomic and Precision Medicine (GPM)

Thomas J. Wang, MD, FAHA

The mission of the American Heart Association Council on Genomic and Precision Medicine (GPM) is to advance the discovery and translation of biological insights gained from genetics and omics technologies to improve cardiovascular and brain health. Our constituency’s expertise spans across genetics, genomics, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, population health, clinical genetics and genomic medicine, with the ultimate goal of more precise risk prediction, treatment and prevention for patients and the population. Integral to the American Heart Association’s goals, the GPM Council provides a premier inter-disciplinary forum promoting and integrating new knowledge from molecules to populations in translational cardiovascular science and precision medicine.

Thomas J. Wang, MD, FAHA
Chair, Council on Genomic and Precision Medicine

Scientific Sessions       Circulation: Genomic and Precision Medicine      GPM Council Awards
 

AHA / ASA Professional Members are Difference Makers.